Los Angeles Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-492
Closed -$3.25K 2466
2025
Q4
$3.25K Buy
+492
New +$2.73K ﹤0.01% 2367
2024
Q4
Sell
-15,191
Closed -$430K 1157
2024
Q3
$430K Buy
+15,191
New +$392K ﹤0.01% 903
2023
Q3
Sell
-7,185
Closed -$218K 1155
2023
Q2
$218K Buy
7,185
+144
+2% +$4.66K ﹤0.01% 1100
2023
Q1
$228K Sell
7,041
-1,019
-13% -$32.2K ﹤0.01% 1097
2022
Q4
$226K Buy
+8,060
New +$231K ﹤0.01% 1117
2021
Q2
Sell
-70,881
Closed -$1.43M 1578
2021
Q1
$1.43M Sell
70,881
-2,865
-4% -$54.5K 0.01% 743
2020
Q4
$1.18M Sell
73,746
-5,180
-7% -$68.5K 0.01% 862
2020
Q3
$979K Buy
78,926
+2,340
+3% +$27.5K ﹤0.01% 825
2020
Q2
$545K Buy
76,586
+28,736
+60% +$192K ﹤0.01% 1082
2020
Q1
$260K Buy
47,850
+35,290
+281% +$315K ﹤0.01% 1099
2019
Q4
$114K Buy
12,560
+220
+2% +$1.79K ﹤0.01% 1234
2019
Q3
$89K Buy
+12,340
New +$88.6K ﹤0.01% 1242

Other funds holding EVH

Los Angeles Capital Management's EVH Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 492 shares — an estimated $3.25K sold.

Los Angeles Capital Management first reported a position in EVH in Q3 2019 and held it in 12 quarters. The position peaked at $1.43M in Q1 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 492 Evolent Health shares in Q1 2026, an estimated $3.25K.
  • Los Angeles Capital Management first reported a position in Evolent Health in Q3 2019 and held it in 12 quarters.
  • Los Angeles Capital Management's Evolent Health position peaked at $1.43M in Q1 2021.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.